Drug Name Tocilizumab Drug Class Immunosuppressant Risk minimization type Safety communication Specialty (Theraputic area) Rheumatology Risk Potential Risk of Acute Generalized Exanthematous Pustulosis (AGEP) Associated with the Use of Tocilizumab safety communication